Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Nova Eye Medical.
RELATED STOCKHEAD STORIES
News
Top 10 at 10: $30m stock says offtake deal could net it $18m a year
News
In Case You Missed It: R&D refunds for drug developers and a major uranium merger
Health & Biotech
ASX Health Stocks: Oncosil advances pancreatic cancer device to Greece, its third potential market in Europe
Health & Biotech
ASX Health Stocks: Nova Eye catches a break as US Medicare reimbursement decision deferred until March
Health & Biotech
ASX Health Stocks: Forget surgery, Orthocell says tennis elbow can be fixed with its tendon cell therapy
News
10 at 11ish: Keypath Education eyes profitability in FY24, Metal Bank’s high-grade copper find at Malaqa
Tech
‘Take advantage of market consolidation’: EYE ready for proposed US Medicare changes
Health & Biotech
Curvebeam AI CEO says medical devices beat drugs to revenue, massive market in medical imaging
Health & Biotech
Stock Insiders: Nova Eye is confident its new canoplasty device will become a hit
Health & Biotech
Nova Eye’s new iTrack Advance eyes broader market as improves key glaucoma procedure
Health & Biotech
Advance US sales of Nova’s iTrack glaucoma surgery device hits US$2.2m
Health & Biotech
ASX Health Stocks: PYC granted FDA Fast Track; BCAL announces breakthrough results
Health & Biotech
These were the best ASX biotechs as Health Care sprang back to life in FY23
Health & Biotech
Which ASX health companies are making strides in world’s largest healthcare market?
Experts
Dr Boreham’s Crucible: Will the US embrace Nova Eye’s vision for the future?
Experts
SUNDAY ROAST: The small caps that lit a fire under Stockhead’s experts this week
Experts